Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Pregnancy, Postpartum Infections : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
References

Related Articles
Cellulitis

Pelvic Inflammatory Disease

Urinary Tract Infection, Female

Vaginitis




Patient Education
Pregnancy and Reproduction Center

Postpartum Perineal Care Overview

Postpartum Perineal Care Symptoms

Postpartum Perineal Care Follow-up and Treatment




Author: Elicia S Kennedy, MD, Clinical Assistant Professor, Department of Emergency Medicine, University of Arkansas for Medical Sciences

Elicia S Kennedy is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine

Editors: Assaad J Sayah, MD, Chief, Department of Emergency Medicine, Cambridge Health Alliance; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Mark Zwanger, MD, MBA, Assistant Professor, Department of Emergency Medicine, Thomas Jefferson University; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; Pamela L Dyne, MD, Associate Professor, Program Director, Department of Medicine, Division of Emergency Medicine, University of California at Los Angeles School of Medicine

Author and Editor Disclosure

Synonyms and related keywords: endometritis, puerperal infection, postsurgical wound infections, perineal cellulitis, mastitis, respiratory complications from anesthesia, retained products of conception, urinary tract infections, UTI, septic pelvic phlebitis, mastitis, pyelonephritis, genital tract infections, thrombosis, perineal cellulitis, episiotomy, Bacteroides, Clostridium, Escherichia coli, E coli, Staphylococcus aureus, S aureus, Klebsiella, Proteus, Enterobacter

Background

Emergency physicians are increasingly concerned about postpartum patients who come to the ED with a fever or evidence of infection. The number of cases of infection can be expected to increase because of the earlier discharge of postpartum patients from the hospital. Any infection following delivery is classified as postpartum or puerperal infection.

Pathophysiology

Endometritis is the most common source of postpartum infection. Other sources of postpartum infections include (1) postsurgical wound infections, (2) perineal cellulitis, (3) mastitis, (4) respiratory complications from anesthesia, (5) retained products of conception, (6) urinary tract infections (UTIs), and (7) septic pelvic phlebitis.

Frequency

United States

Overall, postpartum infection is estimated to occur in 1-8% of all deliveries.

Mortality/Morbidity

In most reviews, maternal death rates associated with infection range from 4-8%, or approximately 0.6 maternal deaths per 100,000 live births.



History

The history and course of the delivery is important in the evaluation of postpartum patients.

  • Ascertain if the delivery was vaginal or cesarean.
  • Ascertain if premature rupture of the membranes occurred.
  • Assess the patient's symptoms.
  • Features vary depending on the source of infection and may include the following:
    • Flank pain, dysuria, and frequency of UTIs
    • Erythema and drainage from the surgical incision or episiotomy site, in cases of postsurgical wound infections
    • Respiratory symptoms, such as cough, pleuritic chest pain, or dyspnea, in cases of respiratory infection or septic pulmonary embolus
    • Fever and chills
    • Abdominal pain
    • Foul-smelling lochia
    • Breast engorgement in cases of mastitis

Physical

Focus the physical examination on identifying the source of fever and infection. A complete physical examination, including pelvic and breast examinations, is necessary. Findings may include the following:

  • Endometritis may be characterized by lower abdominal tenderness on one or both sides of the abdomen, adnexal and/or parametrial tenderness elicited with bimanual examination, temperature elevation (most commonly >38.3°C)
  • Some women have foul-smelling lochia without other evidence of infection. Some infections, most notably caused by group A beta-hemolytic streptococci, are frequently associated with scanty, odorless lochia.
  • Patients with wound infections, or episiotomy infections, have erythema, edema, tenderness, and discharge from the wound or episiotomy site.
  • Patients with mastitis have very tender, engorged, erythematous breasts. Infection frequently is unilateral.
  • Patients with pyelonephritis or UTIs may have tenderness at the costovertebral angle and an elevated temperature.
  • Respiratory signs, such as rales, consolidation, or rhonchi in pneumonia, are possible.
  • Patients with septic pelvic thrombosis, although rare, may have palpable pelvic veins. These patients also have tachycardia that is out of proportion to the fever.

Causes

Causes and risk factors may include the following:

  • Endometritis
    • In most cases of endometritis, the bacteria responsible for pelvic infections are those that normally reside in the bowel, vagina, perineum, and cervix.
    • The uterine cavity is usually sterile until the rupture of the amniotic sac. As a consequence of labor, delivery, and associated manipulations, anaerobic and aerobic bacteria can contaminate the uterus.
    • The risk of endometritis increases dramatically after cesarean delivery (10-20% of patients).
  • Genital tract infections
    • Genital tract infections are generally polymicrobial.
    • Gram-positive cocci and Bacteroides and Clostridium species are the predominant anaerobic organisms involved. Escherichia coli and gram-positive cocci are commonly involved aerobes.
  • Mastitis
    • The most common organism reported in mastitis is Staphylococcus aureus.
    • The organism usually comes from the breastfeeding infant's mouth or throat.
  • Thrombosis
    • Numerous factors cause pregnant and postpartum women to be more susceptible to thrombosis. Pregnancy is known to induce a hypercoagulable state secondary to increased levels of clotting factors. Also, venous stasis occurs in the pelvic veins during pregnancy.
    • Although relatively rare, septic pelvic thrombosis is occasionally observed in the postpartum patient, who might have fever.
  • Perineal cellulitis and episiotomy site infections
    • Most often, the etiologic organisms associated with perineal cellulitis and episiotomy site infections are Staphylococcus or Streptococcus species and gram-negative organisms, as in endometritis.
    • Vaginal secretions contain as many as 10 billion organisms per gram of fluid. Yet, infections develop in only 1% of patients who had vaginal tears or who underwent episiotomies.
  • Urinary tract infections
    • Bacteria most frequently found in UTIs are normal bowel flora, including E coli and Klebsiella, Proteus, and Enterobacter species.
    • Any form of invasive manipulation of the urethra (eg, Foley catheterization) increases the likelihood of a UTI.
  • Risk factors
    • History of cesarean delivery
    • Premature rupture of membranes
    • Frequent cervical examination (Sterile gloves should be used in examinations. Other than a history of cesarean delivery, this risk factor is most important in postpartum infection.)
    • Internal fetal monitoring
    • Preexisting pelvic infection
    • Diabetes
    • Nutritional status
    • Obesity



Cellulitis
Pelvic Inflammatory Disease
Urinary Tract Infection, Female
Vaginitis

Other Problems to be Considered

Endometritis
Mastitis
Retained products of conception
Septic pelvic phlebitis



Lab Studies

  • Complete blood count
  • Blood cultures, if sepsis is suspected
  • Urinalysis, with cultures and sensitivity tests
  • Cervical or uterine cultures
  • Wound cultures, if appropriate

Imaging Studies

  • Pelvic ultrasonography may be helpful in detecting a pelvic abscess or infected hematoma. In some cases, a contrast computed tomography examination of the abdomen and pelvis may be helpful if concurrent concern is present for other non-pregnancyrelated abdominal/pelvic sources of the infection (eg, appendicitis, colitis).



Prehospital Care

The most important aspect of prehospital care in a postpartum patient with a suspected infection is to ensure adequate fluid volume and to prevent sepsis and shock.

  • Provide aggressive fluid management.
  • Begin cardiac monitoring and administer oxygen.

Emergency Department Care

ED care is focused on identifying the source of the infection, followed by appropriate antimicrobial therapy and referral.

  • Postpartum endometritis treatment
    • Mild cases of endometritis after vaginal delivery may be treated with oral antimicrobial agents (such as doxycycline or clindamycin).
    • Moderate-to-severe cases, including those involving cesarean deliveries, should be treated with parenteral broad-spectrum antimicrobials (cefoxitin with doxycycline or clindamycin).
    • A rapid response to antibiotics is the typical response in the treatment of postpartum endometritis.
  • Mastitis treatment
    • Administer dicloxacillin, penicillinase-resistant penicillin, or clindamycin, and use local measures, such as ice packs, analgesics, and breast support.
    • The mother should be told to continue to breastfeed the baby, because breastfeeding is not harmful to the child.
    • Mastitis could lead to abscess formation, which may require surgical drainage.
  • UTI treatment
    • Administer fluids, if evidence of dehydration exists.
    • Appropriate antibiotics may be used.
  • Septic pelvic phlebitis treatment
    • Anticoagulation may be used.
    • Broad-spectrum antibiotics may be administered.
  • Wound infection or episiotomy infection treatment
    • Drainage, debridement, and irrigation may be required.
    • Broad-spectrum antibiotics may be administered.

Consultations

Consult an obstetrician.



Antibiotics are the mainstay of treatment. Pain medications also are important, because patients often have discomfort. Patients with septic pelvic thrombophlebitis must undergo anticoagulation therapy, and they should receive broad-spectrum antibiotics.

Drug Category: Antibiotics

Antibiotic coverage for Bacteroides group B and A streptococci, Enterobacteriaceae organisms, and Chlamydia trachomatis in endometritis is suggested. Wound and episiotomy site infections need broad-spectrum antibiotics as well, because of the polymicrobial nature of the local flora. Consider coverage primarily for S aureus in postpartum mastitis.

Drug NameCefoxitin (Mefoxin)
DescriptionSecond-generation cephalosporin indicated for gram-positive coccal and gram-negative rod infections. Infections caused by cephalosporin-resistant or penicillin-resistant gram-negative bacteria may respond to cefoxitin. Must be used with clindamycin or doxycycline and an aminoglycoside for the treatment of endometritis, for which it is a DOC. Particularly important in early postpartum (first 48 h) infections.
Adult Dose2 g IV q6-8h
Pediatric Dose80-160 mg/kg/d IV divided q4-6h; higher doses for more severe infections; not to exceed 12 g/d
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid may increase effects; concurrent use with aminoglycosides or furosemide may increase nephrotoxicity (closely monitor renal function)
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsBacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged use or repeated treatment; caution in previously diagnosed colitis

Drug NameDoxycycline (Bio-Tab, Doryx)
DescriptionInhibits protein synthesis and thus bacterial growth by binding to 30S and possibly 50S ribosomal subunits of susceptible bacteria. Must be used with other drugs for endometritis. Used often for outpatient therapy for late postpartum (48 h to 6 wk after delivery) treatment.
Adult Dose100 mg PO/IV q12h for 14 d
Pediatric Dose<8 years: Contraindicated
>8 years: 2-5 mg/kg/d PO/IV qd or divided bid
ContraindicationsDocumented hypersensitivity; severe hepatic dysfunction
InteractionsBioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; tetracyclines can increase hypoprothrombinemic effects of anticoagulants; tetracyclines can decrease effects of oral contraceptives, causing breakthrough bleeding and increased risk of pregnancy
PregnancyD - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
PrecautionsPhotosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last half of pregnancy through age 8 y) can permanently discolor teeth; Fanconi-like syndrome may occur with outdated tetracyclines

Drug NameGentamicin (Garamycin)
DescriptionAminoglycoside antibiotic used for gram-negative bacterial coverage. Commonly used with an agent against gram-positive organisms in treatment of endometritis. Not the DOC. Consider if penicillins or other less toxic drugs are contraindicated, when clinically indicated, and in mixed infections caused by susceptible staphylococci and gram-negative organisms. Dosing regimens are numerous and adjusted on the basis of CrCl and changes in volume of distribution. Gentamicin may be given IV/IM.
Adult Dose1 mg/kg IV q12h
Pediatric Dose<5 years: Not established
>5 years: 1.5-2.5 mg/kg/dose IV/IM q8h or 6-7.5 mg/kg/d IV/IM divided q8h; not to exceed 300 mg/d
ContraindicationsDocumented hypersensitivity; non–dialysis-dependent renal insufficiency
InteractionsCoadministration with other aminoglycosides, cephalosporins, penicillins, and amphotericin B may increase nephrotoxicity; aminoglycosides enhance effects of neuromuscular blocking agents thus prolong respiratory depression; coadministration with loop diuretics may increase auditory toxicity of aminoglycosides; possible irreversible hearing loss of varying degrees may occur (monitor regularly)
PregnancyC - Fetal risk revealed in studies in animals but not established or not studies in humans; may use if benefits outweigh risk to fetus
PrecautionsNarrow therapeutic index (not intended for long-term therapy); caution in renal failure (patients not undergoing dialysis), myasthenia gravis, hypocalcemia, and conditions that depress neuromuscular transmission; adjust dose in renal impairment

Drug NameClindamycin (Cleocin)
DescriptionInhibits bacterial protein synthesis by inhibiting peptide chain initiation at the bacterial ribosome where it binds preferentially to the 50S ribosomal subunit, causing bacterial growth inhibition. Must be used with other drugs in the treatment of endometritis. Second drug of choice, after dicloxacillin, in postpartum mastitis.
Adult Dose450-900 mg IV/IM q8h or 300 mg PO q6h
Pediatric Dose20-40 mg/kg/d IV/IM divided tid/qid or 8-20 mg/kg/d PO as hydrochloride, with 8-25 mg/kg/d as palmitate divided tid/qid
ContraindicationsDocumented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis
InteractionsIncreases duration of neuromuscular blockade, induced by tubocurarine and pancuronium; erythromycin may antagonize effects; antidiarrheals may delay absorption
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsAdjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis

Drug NameDicloxacillin (Dycill, Dynapen, Pathocil)
DescriptionBactericidal antibiotic that inhibits cell wall synthesis. Used in treatment of infections caused by penicillinase-producing staphylococci. Primary drug of choice used for postpartum mastitis to cover S aureus.
Adult Dose500 mg PO q6h
Pediatric Dose<40 kg: 12.5 mg/kg/d PO q6h
>40 kg: 125 mg PO q6h
ContraindicationsDocumented hypersensitivity
InteractionsDecreases efficacy of oral contraceptives; increases effects of anticoagulants; probenecid and disulfiram may increase penicillin levels; concurrent tetracyclines may decrease effectiveness
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsMonitor PT in patients taking anticoagulant medications; toxicity may increase in renal impairment

Drug NameMetronidazole (Flagyl)
DescriptionUsed with heparin and third-generation parenteral cephalosporin in the treatment of septic pelvic vein thrombophlebitis to cover streptococci and Bacteroides and Enterobacteriaceae species.
Adult Dose500 mg PO/IV q6h
Pediatric Dose15-30 mg/kg/d PO/IV divided bid/tid for 7 d
ContraindicationsDocumented hypersensitivity
InteractionsMay increase toxicity of anticoagulants, lithium, and phenytoin; cimetidine may increase toxicity; disulfiram reaction may occur with orally ingested ethanol
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsAdjust dose in hepatic disease; monitor for seizures and development of peripheral neuropathy

Drug NameCephalexin (Keflex)
DescriptionFirst-generation cephalosporin used to cover S aureus in mastitis. Encourage the mother to continue breastfeeding to shorten duration of symptoms. Another DOC for postpartum mastitis.
Adult Dose500 mg PO qid for 10-14 d
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsCoadministration with aminoglycosides increase nephrotoxic potential
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsAdjust dose in renal impairment



Further Inpatient Care

  • Patients with early postpartum endometritis (especially after cesarean delivery) should be admitted, as should any patient with suspected septic pelvic vein thrombosis.

Further Outpatient Care

  • All patients with a postpartum infection should undergo follow-up with an obstetrician.

Complications

  • Scarring
  • Infertility
  • Sepsis
  • Septic shock
  • Death

Prognosis

  • The prognosis is good with prompt and appropriate therapy.

Patient Education



Medical/Legal Pitfalls

  • Failure to diagnose
  • Inappropriate antibiotics



  • Atrash HK, Koonin LM, Lawson HW, Franks AL, Smith JC. Maternal mortality in the United States, 1979-1986. Obstet Gynecol. Dec 1990;76(6):1055-60. [Medline].
  • Chaim W, Bashiri A, Bar-David J, et al. Prevalence and clinical significance of postpartum endometritis and wound infection. Infect Dis Obstet Gynecol. 2000;8(2):77-82. [Medline].
  • Cohen J, Powderly W. Episiotomy infections and postabortion sepsis. In: Infectious Diseases. 2nd ed. 2004:697-698.
  • Cunningham FG, MacDonald PC, Gant NF. Infections and disorders of the puerperium. In: William's Obstetrics. 20th ed. 1997:547-68.
  • Del Priore G, Jackson-Stone M, Shim EK, et al. A comparison of once-daily and 8-hour gentamicin dosing in the treatment of postpartum endometritis. Obstet Gynecol. Jun 1996;87(6):994-1000. [Medline].
  • Faro S. Postpartum endometritis. In: Obstetrics and Gynecologic Infectious Disease. 1994:427-36.
  • French LM, Smaill FM. Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev. 2002;CD001067. [Medline].
  • Gabbe, SG. Puerperal endometritis, serious sequelae of puerperal infection. In: Obstetrics: Normal and Problem Pregnancies. 4th ed. 2002:1304-1308.
  • Gibbs RS. Clinical risk factors for puerperal infection. Obstet Gynecol. May 1980;55(5 Suppl):178S-184S. [Medline].
  • Gilstrap LC, Faro S. Postpartum endometritis. In: Infections in Pregnancy. 2nd ed. 1997:65-78.
  • Monga M, Oshiro BT. Puerperal infections. Semin Perinatol. Dec 1993;17(6):426-31. [Medline].
  • Rochat RW, Koonin LM, Atrash HK, Jewett JF. Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol. Jul 1988;72(1):91-7. [Medline].
  • Sweet RL, Gibbs RS. Postpartum infection. In: Infectious Diseases of the Female Genital Tract. 3rd ed. 1995:578-600.

Pregnancy, Postpartum Infections excerpt

Article Last Updated: Aug 8, 2007